1. Home
  2. STVN vs CRVL Comparison

STVN vs CRVL Comparison

Compare STVN & CRVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • CRVL
  • Stock Information
  • Founded
  • STVN 1949
  • CRVL 1987
  • Country
  • STVN Italy
  • CRVL United States
  • Employees
  • STVN N/A
  • CRVL N/A
  • Industry
  • STVN Containers/Packaging
  • CRVL Specialty Insurers
  • Sector
  • STVN Consumer Discretionary
  • CRVL Finance
  • Exchange
  • STVN Nasdaq
  • CRVL Nasdaq
  • Market Cap
  • STVN 6.2B
  • CRVL 5.6B
  • IPO Year
  • STVN 2021
  • CRVL 1991
  • Fundamental
  • Price
  • STVN $22.88
  • CRVL $108.85
  • Analyst Decision
  • STVN Buy
  • CRVL
  • Analyst Count
  • STVN 6
  • CRVL 0
  • Target Price
  • STVN $27.50
  • CRVL N/A
  • AVG Volume (30 Days)
  • STVN 373.4K
  • CRVL 134.3K
  • Earning Date
  • STVN 03-06-2025
  • CRVL 01-28-2025
  • Dividend Yield
  • STVN 0.25%
  • CRVL N/A
  • EPS Growth
  • STVN N/A
  • CRVL 9.77
  • EPS
  • STVN 0.48
  • CRVL 1.57
  • Revenue
  • STVN $1,220,254,294.00
  • CRVL $845,638,000.00
  • Revenue This Year
  • STVN $3.01
  • CRVL N/A
  • Revenue Next Year
  • STVN $7.07
  • CRVL N/A
  • P/E Ratio
  • STVN $48.10
  • CRVL $69.33
  • Revenue Growth
  • STVN 3.53
  • CRVL 12.66
  • 52 Week Low
  • STVN $16.56
  • CRVL $74.63
  • 52 Week High
  • STVN $34.73
  • CRVL $127.24
  • Technical
  • Relative Strength Index (RSI)
  • STVN 56.08
  • CRVL 43.32
  • Support Level
  • STVN $21.42
  • CRVL $108.70
  • Resistance Level
  • STVN $24.38
  • CRVL $112.10
  • Average True Range (ATR)
  • STVN 1.24
  • CRVL 2.74
  • MACD
  • STVN -0.08
  • CRVL -0.09
  • Stochastic Oscillator
  • STVN 59.95
  • CRVL 44.73

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About CRVL CorVel Corp.

CorVel Corp applies technology including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. It partners with employers, third-party administrators, insurance companies, and government agencies in managing worker's compensation and health, auto, and liability services. The company's solutions combine integrated technologies with a human touch providing services that include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care, and medicare services.

Share on Social Networks: